LEXARIA BIOSCIENCE CORP.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $63.6K | $40.7K | $14.7K | $0 |
| Cost of Revenue | $29.8K | $45.6K | $29.9K | $0 |
| Gross Profit | $33.9K | $-4.9K | $-15.2K | $0 |
| Gross Margin | 53.3% | -12.0% | -103.3% | — |
| Operating Expenses | ||||
| Research & Development | $54.2K | $9.0K | $146.5K | $0 |
| SG&A Expense | $129.7K | $133.7K | $18.8K | $11.6K |
| Operating Income | $-1.9M | $-1.3M | $-2.0M | $-1.6M |
| Operating Margin | -3,028.7% | -3,136.8% | -13,489.8% | — |
| Interest Expense | $6.0K | $2.3K | $31.5K | $165.8K |
| Pretax Income | $-1.9M | $-1.3M | — | $-1.6M |
| Income Tax Expense | $0 | $0 | — | — |
| Net Income | $-1.9M | $-1.3M | $-2.0M | $-1.6M |
| Net Margin | -3,031.9% | -3,136.8% | -13,489.8% | — |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.04 | $-0.14 |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.04 | $-0.14 |
| Shares Outstanding (Basic) | 69.4M | 52.4M | 43.8M | 34.4M |
| Shares Outstanding (Diluted) | 69.4M | 52.4M | 43.8M | 34.4M |
| Dividends Per Share | — | — | — | — |